Raúl Díaz-Molina

7PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisCancer geneticsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Nrf2 Is Associated with Metastasis-Related Processes in a Chemoresistant Breast Cancer Model: Insights from siRNA Modulation.

|Sep 28, 2024
Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model.

Angel Pulido-Capiz, Brenda Chimal-Vega, Luis Pablo Avila-Barrientos

|Apr 27, 2024
Low-Density Lipoproteins Increase Proliferation, Invasion, and Chemoresistance via an Exosome Autocrine Mechanism in MDA-MB-231 Chemoresistant Cells.

César Y Castañeda-Sánchez, Brenda Chimal-Vega, Roberto León-Gutiérrez

|Jun 10, 2023
A Triazaspirane Derivative Inhibits Migration and Invasion in PC3 Prostate Cancer Cells.

Javier de Jesús Vasconcelos-Ulloa, Victor García-González, Benjamín Valdez-Salas

|Dec 23, 2022
eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model.

Alina González-Ortiz, Angel Pulido-Capiz, César Y Castañeda-Sánchez

|Aug 25, 2022
LDL Promotes Disorders in β-Cell Cholesterol Metabolism, Implications on Insulin Cellular Communication Mediated by EVs.

Lizbeth Guevara-Olaya, Brenda Chimal-Vega, César Yahel Castañeda-Sánchez

Pageof 2

Frequent Collaborators

7 joint publications

Victor García-González

5 joint publications

Octavio Galindo-Hernández

3 joint publications

Angel Pulido-Capiz

3 joint publications

Nicolás Serafín-Higuera